NovaSterilis, Inc., a biotechnology company, is organized around development and commercialization of supercritical carbon dioxide (SCCO2) technology for biomedical applications. Sterilization using supercritical carbon dioxide (SCCO2) involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes SCCO2 ideal for materials which are temperature sensitive or reactive with other forms of sterilization. The company offers NOVA 2200, a SCCO2 sterilizer, which is used to sterilize various types of allograft and engineered tissues, including skin, ligament, tendon, and bone without damage to the products structural or chemical integrity, and achieves Sterility Assurance Level of 10-6 (SAL6).
